Background The prevalence of chronic skin wounds in humans is high, and treatment is
often complicated by the presence of pathogenic bacteria. Therefore, safe and innovative …

ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …

Mesenchymal stem cells (MSCs) are present in all organs and tissues, playing a well-known
function in tissue regeneration. However, there is also evidence indicating a broader role of …

Acute inflammatory diseases such as acute colitis, kidney injury, liver failure, lung injury,
myocardial infarction, pancreatitis, septic shock, and spinal cord injury are significant causes …

Introduction: Mesenchymal stromal (stem) cell (MSC) therapies are emerging as a promising
therapeutic intervention in patients with Acute Respiratory Distress Syndrome (ARDS) and …

Acute respiratory distress syndrome (ARDS) is a life-threatening inflammatory lung condition
associated with significant morbidity and mortality. Unfortunately, the current treatment for …

The acute respiratory distress syndrome (ARDS) is a multifaceted lung disorder in which no
specific therapeutic intervention is able to effectively improve clinical outcomes. Despite an …

Abstract Editor's Perspective What We Already Know about This Topic Mesenchymal stromal
cells are multipotent adult stem cells with the capacity to differentiate into multiple cell types …

In experimental models, mesenchymal stem cells (MSCs) can modulate various immune
responses implicated in the pathogenesis of sepsis. Intravenous injection of …

The emergence of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) at the
end of 2019 in Hubei province China, is now the cause of a global pandemic present in over …